Trials / Unknown
UnknownNCT05127772
A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing
A Randomized, Double-Blind, Placebo-Controlled Study of Ascending Single and Multiple Doses to Evaluate the Safety, Tolerability, PK, PDand Randomized, Open-label，Crossover, Food Effect Study of HEC93077 in Healthy Chinese Subjects and Hyperuricemia Patients
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 126 (estimated)
- Sponsor
- Sunshine Lake Pharma Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
A phase 1 clinical trial of HEC93077,to evaluate the safety ,PK,PD and food effect in Chinese healthy subjects and HUA patients after single or multiple dosing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HEC93077 | Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days |
| DRUG | Placebo | Paticipants recieve placebo matching HEC93077 orally single or Mulltiple doses up to 14 days |
Timeline
- Start date
- 2021-11-22
- Primary completion
- 2023-10-25
- Completion
- 2023-11-25
- First posted
- 2021-11-19
- Last updated
- 2023-04-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05127772. Inclusion in this directory is not an endorsement.